HCS Pharma Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 21

Employees

  • Latest Deal Type
  • M&A

HCS Pharma General Information

Description

Developer of a biomimetic three-dimensional technology designed to facilitate in vitro research and development. The company's technology offers an innovative cell imaging technology that assists in high-throughput and high-content screening of molecules for the identification of new drugs, enabling researchers to reduce the cost of research and get more predictive results in vitro studies.

Contact Information

Website
www.hcs-pharma.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Siège de Lille, Biocentre Fleming
  • 250 rue Salvador, Allende, Bat A
  • 59120 Lille
  • France
+33 07
Primary Industry
Biotechnology
Acquirer
NETRI
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Siège de Lille, Biocentre Fleming
  • 250 rue Salvador, Allende, Bat A
  • 59120 Lille
  • France
+33 07

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HCS Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 25-Mar-2025 Completed Generating Revenue
7. Equity Crowdfunding Completed Generating Revenue
6. Grant 07-Sep-2023 Completed Generating Revenue
5. Later Stage VC 23-Jul-2019 Completed Generating Revenue
4. Early Stage VC 28-Sep-2018 Completed Generating Revenue
3. Early Stage VC 14-Dec-2016 Completed Generating Revenue
2. Accelerator/Incubator 01-Dec-2015 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view HCS Pharma’s complete valuation and funding history, request access »

HCS Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
AP2018
Ordinary
To view HCS Pharma’s complete cap table history, request access »

HCS Pharma Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

HCS Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4314246-A1 Liver organoid manufacturing methods, liver organoids obtained with the same, and uses thereof Pending 01-Apr-2021
US-12767931-B2 Liver organoid manufacturing methods, liver organoids obtained with the same, and uses thereof Active 01-Apr-2021
US-20240279612-A1 Liver organoid manufacturing methods, liver organoids obtained with the same, and uses thereof Active 01-Apr-2021
WO-2022207889-A1 Liver organoid manufacturing methods, liver organoids obtained with the same, and uses thereof Inactive 01-Apr-2021
EP-3538140-A1 Methods and pharmaceutical compositions for modulating stem cells proliferation or differentiation Inactive 14-Nov-2016 C12N15/1137
To view HCS Pharma’s complete patent history, request access »

HCS Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HCS Pharma Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angels Santé Angel Group Minority
Emergys (France) Accelerator/Incubator
Eurasanté PE-Backed Company Minority
Finovam Gestion Venture Capital Minority
Nord France Amorçage Venture Capital Minority
To view HCS Pharma’s complete investors history, request access »

Ready to get started?

Request a free trial

HCS Pharma FAQs

  • When was HCS Pharma founded?

    HCS Pharma was founded in 2014.

  • Where is HCS Pharma headquartered?

    HCS Pharma is headquartered in Lille, France.

  • What is the size of HCS Pharma?

    HCS Pharma has 21 total employees.

  • What industry is HCS Pharma in?

    HCS Pharma’s primary industry is Biotechnology.

  • Is HCS Pharma a private or public company?

    HCS Pharma is a Private company.

  • What is HCS Pharma’s current revenue?

    The current revenue for HCS Pharma is .

  • How much funding has HCS Pharma raised over time?

    HCS Pharma has raised $1.91M.

  • Who are HCS Pharma’s investors?

    Angels Santé, Emergys (France), Eurasanté, Finovam Gestion, and Nord France Amorçage have invested in HCS Pharma.

  • When was HCS Pharma acquired?

    HCS Pharma was acquired on 25-Mar-2025.

  • Who acquired HCS Pharma?

    HCS Pharma was acquired by NETRI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process